<DOC>
	<DOCNO>NCT01232491</DOCNO>
	<brief_summary>This trial conduct Europe , North South America . The aim trial investigate dietary intervention effect weight initiate insulin treatment subject type 2 diabetes currently treat oral antidiabetic drug ( OADs ) .</brief_summary>
	<brief_title>Impact Dietary Intervention Weight Change Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Body Weight Changes</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Type 2 diabetes ( diagnose clinically ) least 6 month prior trial start Insulin naive subject HbA1c : 7.09.0 % ( inclusive ) Body Mass Index ( BMI ) : 25.045.0 kg/m^2 ( inclusive ) Use Thiazolidinedione ( TZDs ) Glucagonlike peptide1 analogue ( GLP 1 ) receptor agonist within last 3 month prior trial enrollment Cardiovascular disease within last 6 month Recurrent severe hypoglycaemia hypoglycaemic unawareness hospitalisation diabetic ketoacidosis previous 6 month Uncontrolled treated/untreated severe hypertension , impair liver function , impaired renal function , know proliferative retinopathy maculopathy require treatment Cancer medical history cancer past 5 year ( except basal cell skin cancer squamous cell skin cancer ) Pregnancy , breastfeeding , intention become pregnant use adequate contraceptive measure accord local requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>